vs

Side-by-side financial comparison of CME Group (CME) and MKS INC (MKSI). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× MKS INC). MKS INC runs the higher net margin — 7.8% vs 0.1%, a 7.7% gap on every dollar of revenue. On growth, MKS INC posted the faster year-over-year revenue change (15.2% vs 14.5%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 10.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

MKS, Inc is a subsidiary of PTC, Inc. It was previously a multinational independent software vendor that was acquired by Parametric Technology Corporation on May 31, 2011. MKS operated in the Application Lifecycle Management (ALM) and Systems Administration market segments.

CME vs MKSI — Head-to-Head

Bigger by revenue
CME
CME
1.7× larger
CME
$1.9B
$1.1B
MKSI
Growing faster (revenue YoY)
MKSI
MKSI
+0.7% gap
MKSI
15.2%
14.5%
CME
Higher net margin
MKSI
MKSI
7.7% more per $
MKSI
7.8%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
10.2%
MKSI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
MKSI
MKSI
Revenue
$1.9B
$1.1B
Net Profit
$1.2M
$84.0M
Gross Margin
47.0%
Operating Margin
0.1%
13.8%
Net Margin
0.1%
7.8%
Revenue YoY
14.5%
15.2%
Net Profit YoY
20.7%
61.5%
EPS (diluted)
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
MKSI
MKSI
Q1 26
$1.9B
$1.1B
Q4 25
$1.6B
$1.0B
Q3 25
$1.5B
$988.0M
Q2 25
$1.7B
$973.0M
Q1 25
$1.6B
$936.0M
Q4 24
$1.5B
$935.0M
Q3 24
$1.6B
$896.0M
Q2 24
$1.5B
$887.0M
Net Profit
CME
CME
MKSI
MKSI
Q1 26
$1.2M
$84.0M
Q4 25
$1.2B
$107.0M
Q3 25
$908.0M
$74.0M
Q2 25
$1.0B
$62.0M
Q1 25
$956.2M
$52.0M
Q4 24
$874.6M
$90.0M
Q3 24
$912.8M
$62.0M
Q2 24
$883.2M
$23.0M
Gross Margin
CME
CME
MKSI
MKSI
Q1 26
47.0%
Q4 25
46.3%
Q3 25
46.7%
Q2 25
46.6%
Q1 25
47.4%
Q4 24
47.3%
Q3 24
48.2%
Q2 24
47.2%
Operating Margin
CME
CME
MKSI
MKSI
Q1 26
0.1%
13.8%
Q4 25
61.8%
13.9%
Q3 25
63.3%
14.0%
Q2 25
66.7%
13.9%
Q1 25
67.5%
11.9%
Q4 24
62.1%
14.7%
Q3 24
64.6%
14.3%
Q2 24
65.3%
14.3%
Net Margin
CME
CME
MKSI
MKSI
Q1 26
0.1%
7.8%
Q4 25
71.7%
10.3%
Q3 25
59.1%
7.5%
Q2 25
60.6%
6.4%
Q1 25
58.2%
5.6%
Q4 24
57.3%
9.6%
Q3 24
57.6%
6.9%
Q2 24
57.6%
2.6%
EPS (diluted)
CME
CME
MKSI
MKSI
Q1 26
$1.18
Q4 25
$3.24
$1.58
Q3 25
$2.49
$1.10
Q2 25
$2.81
$0.92
Q1 25
$2.62
$0.77
Q4 24
$2.40
$1.34
Q3 24
$2.50
$0.92
Q2 24
$2.42
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
MKSI
MKSI
Cash + ST InvestmentsLiquidity on hand
$2.4B
$569.0M
Total DebtLower is stronger
$3.4B
$1.4B
Stockholders' EquityBook value
$2.8B
Total Assets
$202.0B
$8.7B
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
MKSI
MKSI
Q1 26
$2.4B
$569.0M
Q4 25
$4.5B
$418.0M
Q3 25
$2.6B
$413.0M
Q2 25
$2.1B
$498.0M
Q1 25
$1.5B
$407.0M
Q4 24
$3.0B
$420.0M
Q3 24
$2.4B
$439.0M
Q2 24
$1.9B
$506.0M
Total Debt
CME
CME
MKSI
MKSI
Q1 26
$3.4B
$1.4B
Q4 25
$4.2B
Q3 25
$4.3B
Q2 25
$4.4B
Q1 25
$4.4B
Q4 24
$4.5B
Q3 24
$4.8B
Q2 24
$4.8B
Stockholders' Equity
CME
CME
MKSI
MKSI
Q1 26
$2.8B
Q4 25
$28.7B
$2.7B
Q3 25
$28.2B
$2.6B
Q2 25
$27.7B
$2.6B
Q1 25
$27.0B
$2.4B
Q4 24
$26.5B
$2.3B
Q3 24
$28.2B
$2.4B
Q2 24
$27.6B
$2.2B
Total Assets
CME
CME
MKSI
MKSI
Q1 26
$202.0B
$8.7B
Q4 25
$198.4B
$8.8B
Q3 25
$187.1B
$8.8B
Q2 25
$179.9B
$8.8B
Q1 25
$157.8B
$8.6B
Q4 24
$137.4B
$8.6B
Q3 24
$137.8B
$9.0B
Q2 24
$123.4B
$8.9B
Debt / Equity
CME
CME
MKSI
MKSI
Q1 26
0.50×
Q4 25
1.53×
Q3 25
1.64×
Q2 25
1.71×
Q1 25
1.87×
Q4 24
1.93×
Q3 24
1.98×
Q2 24
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
MKSI
MKSI
Operating Cash FlowLast quarter
$53.0M
Free Cash FlowOCF − Capex
$29.0M
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters
$403.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
MKSI
MKSI
Q1 26
$53.0M
Q4 25
$1.1B
$142.0M
Q3 25
$968.1M
$197.0M
Q2 25
$1.1B
$165.0M
Q1 25
$1.1B
$141.0M
Q4 24
$1.0B
$176.0M
Q3 24
$1.0B
$163.0M
Q2 24
$776.9M
$122.0M
Free Cash Flow
CME
CME
MKSI
MKSI
Q1 26
$29.0M
Q4 25
$1.1B
$92.0M
Q3 25
$949.7M
$146.0M
Q2 25
$1.0B
$136.0M
Q1 25
$1.1B
$123.0M
Q4 24
$991.7M
$125.0M
Q3 24
$973.2M
$141.0M
Q2 24
$758.7M
$95.0M
FCF Margin
CME
CME
MKSI
MKSI
Q1 26
2.7%
Q4 25
66.8%
8.9%
Q3 25
61.8%
14.8%
Q2 25
61.5%
14.0%
Q1 25
67.1%
13.1%
Q4 24
65.0%
13.4%
Q3 24
61.4%
15.7%
Q2 24
49.5%
10.7%
Capex Intensity
CME
CME
MKSI
MKSI
Q1 26
Q4 25
2.0%
4.8%
Q3 25
1.2%
5.2%
Q2 25
1.1%
3.0%
Q1 25
0.9%
1.9%
Q4 24
1.7%
5.5%
Q3 24
1.9%
2.5%
Q2 24
1.2%
3.0%
Cash Conversion
CME
CME
MKSI
MKSI
Q1 26
0.63×
Q4 25
0.96×
1.33×
Q3 25
1.07×
2.66×
Q2 25
1.03×
2.66×
Q1 25
1.17×
2.71×
Q4 24
1.16×
1.96×
Q3 24
1.10×
2.63×
Q2 24
0.88×
5.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

MKSI
MKSI

Semiconductor$466.0M43%
Electronics & Packaging$321.0M30%
Specialty Industrial$291.0M27%

Related Comparisons